Too Old to Operate1 天
ENBALV: Edoxaban or Warfarin as Anticoagulant After Bioprosthetic Valve Replacement?
In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...
Penumbra price target raised to $250 from $235 at Piper Sandler
Piper Sandler analyst Matt O’Brien raised the firm’s price target on Penumbra (PEN) to $250 from $235 and keeps an Overweight rating on the ...
Too Old to Operate4 天
Safety and Outcomes of Alteplase in Severe Hypoxemic Respiratory Failure in COVID-19
The following is a summary of “Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter ...
The Caledonian Record5 天
Newer Blood Thinner Cuts Odds for Stroke After Heart Valve Surgery
Key Takeaways ...
Daily5 天
Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery: ENBALV Trial Results
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
Patients taking edoxoban after heart valve surgery found to have lower risk of stroke ...
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
News Medical6 天
Edoxaban proves effective in preventing blood clots, stroke after heart valve surgery
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...
AlphaGalileo6 天
Patients taking edoxoban after heart valve surgery had lower risk of stroke, blood clots
Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...